Authors:
KUMPULAINEN EJ
HIRVIKOSKI PP
PUKKALA E
JOHANSSON RT
Citation: Ej. Kumpulainen et al., CANCER RISK AFTER ADJUVANT CHEMOTHERAPY OR CHEMOHORMONAL THERAPY OF BREAST-CANCER, Anti-cancer drugs, 9(2), 1998, pp. 131-134
Authors:
HIRVIKOSKI P
KUMPULAINEN EJ
VIRTANIEMI JA
HELIN HJ
RANTALA I
JOHANSSON RT
JUHOLA M
KOSMA VM
Citation: P. Hirvikoski et al., CYTOPLASMIC ACCUMULATION OF ALPHA-CATENIN IS ASSOCIATED WITH AGGRESSIVE FEATURES IN LARYNGEAL SQUAMOUS-CELL CARCINOMA, International journal of cancer, 79(5), 1998, pp. 546-550
Authors:
PIRINEN RT
TAMMI RH
TAMMI MI
PAAKKO PK
PARKKINEN JJ
AGREN UM
JOHANSSON RT
VIREN MMT
TORMANEN U
SOINI YMJ
KOSMA VM
Citation: Rt. Pirinen et al., EXPRESSION OF HYALURONAN IN NORMAL AND DYSPLASTIC BRONCHIAL EPITHELIUM AND IN SQUAMOUS-CELL CARCINOMA OF THE LUNG, International journal of cancer, 79(3), 1998, pp. 251-255
Authors:
HIRVIKOSKI PP
KUMPULAINEN EJ
JOHANSSON RT
Citation: Pp. Hirvikoski et al., CNF COMBINATION AS ADJUVANT TREATMENT IN BREAST-CANCER PATIENTS IS WELL TOLERATED, Anti-cancer drugs, 8(4), 1997, pp. 376-378
Authors:
HIRVIKOSKI PP
KUMPULAINEN EJ
JOHANSSON RT
Citation: Pp. Hirvikoski et al., HEPATIC TOXICITY CAUSED BY ADJUVANT CMF CNF IN BREAST-CANCER PATIENTSAND REVERSAL BY TAMOXIFEN/, Breast cancer research and treatment, 44(3), 1997, pp. 269-274
Authors:
AUVINEN PK
PARKKINEN JJ
JOHANSSON RT
AGREN UM
TAMMI RH
ESKELINEN MJ
VELIMATTI K
Citation: Pk. Auvinen et al., EXPRESSION OF HYALURONAN IN BENIGN AND MALIGNANT BREAST-LESIONS, International journal of cancer, 74(5), 1997, pp. 477-481